Literature DB >> 7983750

Human immunodeficiency virus type 1 Nef induces accumulation of CD4 in early endosomes.

O Schwartz1, A Dautry-Varsat, B Goud, V Maréchal, A Subtil, J M Heard, O Danos.   

Abstract

We have studied the fate of CD4 in CEM T cells expressing a human immunodeficiency virus type 1 HIV-1 Nef protein. Nef triggered a rapid endocytosis and a degradation of CD4, while most of the p56lck was upheld at the cell membrane. In the presence of Nef, CD4 accumulated in acidic intracellular vesicles that were not stained by antibodies against rab6, a marker of the Golgi apparatus complex. Detection of transferrin in CD4-containing vesicles showed that CD4 was trapped in early endosomes, without significant accumulation of CD4 in late endocytic compartments. Internalization pathways taken by CD4 in Nef+ cells may therefore be different from those observed after treatment with phorbol esters.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7983750      PMCID: PMC188604          DOI: 10.1128/JVI.69.1.528-533.1995

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  32 in total

1.  Association of tyrosine kinase p56lck with CD4 inhibits the induction of growth through the alpha beta T-cell receptor.

Authors:  L Haughn; S Gratton; L Caron; R P Sékaly; A Veillette; M Julius
Journal:  Nature       Date:  1992-07-23       Impact factor: 49.962

2.  The lymphocyte-specific tyrosine protein kinase p56lck is endocytosed in Jurkat cells stimulated via CD2.

Authors:  A Marie-Cardine; I Maridonneau-Parini; M Ferrer; S Danielian; B Rothhut; R Fagard; A Dautry-Varsat; S Fischer
Journal:  J Immunol       Date:  1992-06-15       Impact factor: 5.422

3.  Phosphorylation-dependent down-modulation of CD4 requires a specific structure within the cytoplasmic domain of CD4.

Authors:  J Shin; R L Dunbrack; S Lee; J L Strominger
Journal:  J Biol Chem       Date:  1991-06-05       Impact factor: 5.157

4.  Serine phosphorylation-independent downregulation of cell-surface CD4 by nef.

Authors:  J V Garcia; A D Miller
Journal:  Nature       Date:  1991-04-11       Impact factor: 49.962

5.  Proteolytic cleavage of ricin A chain in endosomal vesicles. Evidence for the action of endosomal proteases at both neutral and acidic pH.

Authors:  J S Blum; M L Fiani; P D Stahl
Journal:  J Biol Chem       Date:  1991-11-25       Impact factor: 5.157

6.  Nef induces CD4 endocytosis: requirement for a critical dileucine motif in the membrane-proximal CD4 cytoplasmic domain.

Authors:  C Aiken; J Konner; N R Landau; M E Lenburg; D Trono
Journal:  Cell       Date:  1994-03-11       Impact factor: 41.582

7.  Genetic characterization of human immunodeficiency virus type 1 nef gene products translated in vitro and expressed in mammalian cells.

Authors:  J Kaminchik; N Bashan; A Itach; N Sarver; M Gorecki; A Panet
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

8.  The simian immunodeficiency virus Nef protein promotes degradation of CD4 in human T cells.

Authors:  A Sanfridson; B R Cullen; C Doyle
Journal:  J Biol Chem       Date:  1994-02-11       Impact factor: 5.157

9.  Trafficking of interleukin 2 and transferrin in endosomal fractions of T lymphocytes.

Authors:  V Duprez; M Smoljanovic; M Lieb; A Dautry-Varsat
Journal:  J Cell Sci       Date:  1994-05       Impact factor: 5.285

10.  The protein tyrosine kinase p56lck inhibits CD4 endocytosis by preventing entry of CD4 into coated pits.

Authors:  A Pelchen-Matthews; I Boulet; D R Littman; R Fagard; M Marsh
Journal:  J Cell Biol       Date:  1992-04       Impact factor: 10.539

View more
  37 in total

1.  Mechanism for down-regulation of CD28 by Nef.

Authors:  T Swigut; N Shohdy; J Skowronski
Journal:  EMBO J       Date:  2001-04-02       Impact factor: 11.598

2.  Human immunodeficiency virus type 1 Nef functions at the level of virus entry by enhancing cytoplasmic delivery of virions.

Authors:  E Schaeffer; R Geleziunas; W C Greene
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

3.  Mechanism of human immunodeficiency virus type 1 localization in CD4-negative thymocytes: differentiation from a CD4-positive precursor allows productive infection.

Authors:  S G Kitchen; C H Uittenbogaart; J A Zack
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

4.  Human immunodeficiency virus type 1 Nef domains required for disruption of major histocompatibility complex class I trafficking are also necessary for coprecipitation of Nef with HLA-A2.

Authors:  Maya Williams; Jeremiah F Roeth; Matthew R Kasper; Tracey M Filzen; Kathleen L Collins
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

5.  Impaired Downregulation of NKG2D Ligands by Nef Proteins from Elite Controllers Sensitizes HIV-1-Infected Cells to Antibody-Dependent Cellular Cytotoxicity.

Authors:  Nirmin Alsahafi; Jonathan Richard; Jérémie Prévost; Mathieu Coutu; Nathalie Brassard; Matthew S Parsons; Daniel E Kaufmann; Mark Brockman; Andrés Finzi
Journal:  J Virol       Date:  2017-07-27       Impact factor: 5.103

6.  Human immunodeficiency virus type 1 Nef increases the efficiency of reverse transcription in the infected cell.

Authors:  O Schwartz; V Maréchal; O Danos; J M Heard
Journal:  J Virol       Date:  1995-07       Impact factor: 5.103

7.  The SH3 domain-binding surface and an acidic motif in HIV-1 Nef regulate trafficking of class I MHC complexes.

Authors:  M E Greenberg; A J Iafrate; J Skowronski
Journal:  EMBO J       Date:  1998-05-15       Impact factor: 11.598

8.  Mechanism of Nef-induced CD4 endocytosis: Nef connects CD4 with the mu chain of adaptor complexes.

Authors:  V Piguet; Y L Chen; A Mangasarian; M Foti; J L Carpentier; D Trono
Journal:  EMBO J       Date:  1998-05-01       Impact factor: 11.598

9.  The Nef protein of human immunodeficiency virus type 1 enhances serine phosphorylation of the viral matrix.

Authors:  S Swingler; P Gallay; D Camaur; J Song; A Abo; D Trono
Journal:  J Virol       Date:  1997-06       Impact factor: 5.103

10.  Functional characterization of human immunodeficiency virus type 1 nef genes in patients with divergent rates of disease progression.

Authors:  N L Michael; G Chang; L A d'Arcy; C J Tseng; D L Birx; H W Sheppard
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.